A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT04477343 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04477343
- Sponsor
- University of Rochester
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-23
- Primary completion
- 2026-05-06
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.